Concern about fetus and newborn committee statement on corticosteroid use [8]

Pediatrics

Volumn 110, Issue 5, 2002, Pages 1034-1035

  Perlman, Jeffrey ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID;

CHRONIC LUNG DISEASE; DRUG EFFICACY; DRUG INDICATION; DRUG USE; FETUS; HUMAN; LETTER; LOW DRUG DOSE; MEDICAL SOCIETY; NEWBORN; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL;

CHRONIC DISEASE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INFORMED CONSENT; LUNG DISEASES; NERVOUS SYSTEM DISEASES; ORGANIZATIONAL POLICY; PEDIATRICS; PREGNANCY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0036843707     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.110.5.1034     Document Type: Letter

References (34)

1. American Academy of Pediatrics, Committee on Fetus and Newborn and Canadian Paediatric Society, Fetus and Newborn Committee. Post-natal corticosteroids to treat or prevent chronic lung disease in preterm infants., Pediatrics,. 2002;109:330-338
2. Taylor C, Shah PS, Dunn MS. Meta-analysis of postnatal steroid use challenged. Pediatrics. 2002;109:716-717
3. Jacobs HC, Chapman RL, Gross I. Premature conclusions on postnatal steroid effects. Pediatrics. 2002;110:200-201
4. Endo Y, Nishimura JI, Kobayashi S, et al. Long-term glucocorticoid treatments decrease cerebral blood flow in the rat hippocampus in association with histological damage. Neuroscience. 1997;79:745-752
5. Tsuneishi S, Takada S, Toshiyuki M, et al. Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein and glial fibrillary acidic protein genes in developing brain. Dev Brain Res. 1991;61:117-123
6. Dunlop SA, Archer MA, Quinlivan JA, Beazley LD, Newnham JP. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med. 1997;6:309-313
7. Diaz R, Fuxe K, Ogren SO., Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine mediated motor activity in male and female rats. Neuroscience. 1997;81:129-140
8. Chen J, Adachi N, Tsubota S, Nagoro T, Arai T. Dexamethasone augments ischemia-induced extracellular accumulation of glutamate in gerbil hippocampus. Euro J Pharm. 1998;347:67-70
9. Horner HC, Packan DR, Sapolsky RM. Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glial. Neuroendocrinology. 1990;52:57-64
10. Behl C, Lezoualch F, Trapp T, et al. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology. 1997;138:101-106
11. McIntosh LJ, Sapolsky RM. Glucocortcoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp Neurol. 1996;141:201-206
12. O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999;104:15-21
13. Pinto-Martin JA, Riolo S, Cnaan A, Holzman C, Susser MW, Paneth N. Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population. Pediatrics. 1995;95:249-254
14. Northway WH Jr, Rosan RC, Porter DY. Pulmonary, disease following respirator therapy of hyaline membrane disease. N Engl J Med. 1967;276:357-368
15. Abman SH, Burchell MF, Schaffer MS, Rosenberg AA. Late sudden unexpected deaths in hospitalized infants with bronchopulmonary dysplasia. Am J Dis Child. 1989;143:815-819
16. Northway WH Jr. Observations on bronchopulmonary dysplasia. J Pediatr. 1979;95:815-817
17. Vohr BR, Bell EF, Oh W. Infants with bronchopulmonary dysplasia. Am J Dis Child. 1982;136:443-447
18. Mayes L, Perke HE, Stahlman MT. Severe bronchopulmonary dysplasia. Acta Paediatr Scand. 1983;72:225-229
19. Lipschitz MH, Seilheimer DK, Wilson GS, et al. Neurodevelopmental status of low birthweight infants with bronchopulmonary dysplasia requiring prolonged oxygen supplementation, J Perinatol. 1985;7:127-132
20. Yu VH, Orgill AA, Bajuk SBL, Astbury J. Growth and development of very low birthweight infants recovering from bronchopulmonary dysplasia. Arch Dis Child. 1983;58:791-794
21. Shankaran S, Szego E, Eizert D, Siegel P., Severe bronchopulmonary dysplasia. Predictors of survival and outcome. Chest. 1984;86:607-610
22. Ellison PH, Farina MA. Progressive central nervous system deterioration: A complication of advanced chronic lung disease of pre-maturity, Ann Neurol. 1980;8:43
23. Campbell LR, McAlister W, Volpe JJ. Neurologic aspects of bronchopulmonary dysplasia. Clin Pediatr. 1998;27:7-13
24. Smith JF, Reynolds EOR, Taghizadeh A. Brain maturation and damage in infants dying from chronic pulmonary insufficiency in the postneo-natal period. Arch Dis Child. 1974;49:359-365
25. Perlman JM, Volpe JJ. Movement disorder of premature infants with severe bronchopulmonary dysplasia: A new syndrome. Pediatrics. 1989;84:215218
26. Ozdemir A, Brown MA, Morgan WJ. Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol. 1997;23:292-306
27. Speer CP. New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate. 2001;79:205-209
28. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neo-natal Research Network, January 1995 through December 1996. Pediatrics. 2001;107(1). Available at: http://www.pediatrics.org/content/full/107/1/el
29. Van Marter LJ, Dammann O, Allred EN, et al. Chorioamnionitis, mechanical ventilation and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002;140:171-176
30. Matsuda T, Nakajima T, Hattori S, et al. Necrotizing funisitis: Clinical significance and association with chronic lung disease in premature infants. Am J Obstet Gynecol. 1997;177:1402-1407
31. Wu YW. Chorioamnionitis as a risk factor for cerebral palsy. JAMA. 2000;282:1417-1424
32. Murphy BP, Inder TE, Huppi PS, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics. 2001;107:217-221
33. Perlman JM. Neurobehavioral deficits in premature graduates of intensive carepotential medical and environmental risk factors. Pediatrics.2001;108:1339-1348
34. Durand M, Mendoza ME, Tantivit P, Kugelman A, McEvoy C. A randomized trial of moderately early low-dose dexamethasone therapy in very low birthweight infants: dynamic pulmonary mechanics, oxy-genation, and ventilation. Pediatrics. 2002;109:262-268